The Role of PBMs in Drug Affordability & Access: Policy Issues & Solutions

Session Description: 

The following  topics will be addressed during the session:

• What are PBMs? (including why they were created and where they went wrong)
• Current PBM trends and business practices that are concerning
• How exactly do PBMs influence price and access for patients? (including how PBMs interfere with providers’ ability to get a needed medicine to a patient)
• What are possible policy solutions and what is Congress considering passing this year?

Please join Sarah Bourland of Patients for Affordable Drugs and Spencer Asay of Doctors for America on Thursday, June 8 at 1 pm ET for a lunch and learn presentation followed by short Q&A period.